Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

August 15, 2012Open Access

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Enzalutamide significantly prolonged the survival of men with metastatic castration-resistant prostate cancer after chemotherapy. (Funded by Medivation and Astellas Pharma Global Development; AFFIRM ClinicalTrials.gov number, NCT00974311.).

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy | Synapse

Cite This Study

Scher et al. (Wed,) studied this question.

synapsesocial.com/papers/69de45b3210a0977fce93bb1 https://doi.org/https://doi.org/10.1056/nejmoa1207506